Wellframe, a Boston, MA-based combines mobile technology and artificial intelligence to amplify caring clinical relationships by engaging patients in personalized care plans, closed $8.5m financing.
The round was led by DFJ, with participation from Formation 8, Waterline Ventures and Queensbridge Venture Partners. In conjunction with the funding, DFJ Partner Emily Melton, joined the company’s board of directors.
Led by Jacob Sattelmair, CEO and Co-Founder, Wellframe enables healthcare stakeholders to amplify and extend caring relationships through the use of mobile technologies, utilizing artificial intelligence and machine learning to maximize patient engagement. Care plans include mental health, diabetes, transplant medicine and others.
The company has completed clinical trials with academic medical centers and plans to announce a number of commercial partnerships in the coming months.
Wellframe closed a $1.5 seed round earlier in 2014 (read here).